Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC, 19084-19085 [2017-08347]

Download as PDF 19084 Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers importers, and exporters of, controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on August 25, 2016, Cambridge Isotope Laboratories, 50 Frontage Road, Andover, Massachusetts 01810 applied to be registered as an importer of the following basic classes of controlled substances: Controlled substance Drug code Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................. Gamma Hydroxybutyric Acid ......................................................................................................................................... Methaqualone ................................................................................................................................................................ Lysergic acid diethylamide ............................................................................................................................................ Marihuana ...................................................................................................................................................................... Tetrahydrocannabinols .................................................................................................................................................. 3,4-Methylenedioxyamphetamine .................................................................................................................................. 3,4-Methylenedioxy-N-ethylamphetamine ..................................................................................................................... 3,4-Methylenedioxymethamphetamine .......................................................................................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................... Butylone ......................................................................................................................................................................... Heroin ............................................................................................................................................................................ Pentobarbital .................................................................................................................................................................. Secobarbital ................................................................................................................................................................... Phencyclidine ................................................................................................................................................................. Cocaine .......................................................................................................................................................................... Dihydrocodeine .............................................................................................................................................................. Ecgonine ........................................................................................................................................................................ Meperidine ..................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................ Fentanyl ......................................................................................................................................................................... The company plans to import the listed controlled substances for analytical research, testing and clinical trials. Dated: April 18, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017–08346 Filed 4–24–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC asabaliauskas on DSK3SPTVN1PROD with NOTICES ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 26, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and SUPPLEMENTARY INFORMATION: Drug code Gamma Hydroxybutyric Acid ......................................................................................................................................... Dihydromorphine ............................................................................................................................................................ Hydromorphinol .............................................................................................................................................................. Methylphenidate ............................................................................................................................................................. Amobarbital .................................................................................................................................................................... Pentobarbital .................................................................................................................................................................. Secobarbital ................................................................................................................................................................... 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 I I I I I I I I I I I I II II II II II II II II II implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on November 22, 2016, Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance VerDate Sep<11>2014 1248 2010 2565 7315 7360 7370 7400 7404 7405 7540 7541 9200 2270 2315 7471 9041 9120 9180 9230 9273 9801 Schedule E:\FR\FM\25APN1.SGM 25APN1 2010 9145 9301 1724 2125 2270 2315 Schedule I I I II II II II 19085 Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices Controlled substance Drug code Codeine .......................................................................................................................................................................... Oxycodone ..................................................................................................................................................................... Hydromorphone ............................................................................................................................................................. Hydrocodone .................................................................................................................................................................. Methadone ..................................................................................................................................................................... Methadone intermediate ................................................................................................................................................ Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................ Morphine ........................................................................................................................................................................ Oripavine ........................................................................................................................................................................ Thebaine ........................................................................................................................................................................ Opium tincture ............................................................................................................................................................... Oxymorphone ................................................................................................................................................................ The company plans to manufacturer the listed controlled substances in bulk for distribution to its customers. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before June 26, 2017. DATES: Dated: April 18, 2017. Louis J. Milione, Assistant Administrator. [FR Doc. 2017–08347 Filed 4–24–17; 8:45 am] Drug Enforcement Administration Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: ADDRESSES: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc. ACTION: Notice of application. The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with asabaliauskas on DSK3SPTVN1PROD with NOTICES Drug code Cathinone ....................................................................................................................................................................... Methcathinone ............................................................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................. Aminorex ........................................................................................................................................................................ Alpha-ethyltryptamine .................................................................................................................................................... Lysergic acid diethylamide ............................................................................................................................................ Tetrahydrocannabinols .................................................................................................................................................. 4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................ 4-Bromo-2,5-dimethoxyphenethylamine ........................................................................................................................ 4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................ 2,5-Dimethoxyamphetamine .......................................................................................................................................... 3,4-Methylenedioxyamphetamine .................................................................................................................................. N-Hydroxy-3,4-methylenedioxyamphetamine ................................................................................................................ 3,4-Methylenedioxy-N-ethylamphetamine ..................................................................................................................... 3,4-Methylenedioxymethamphetamine .......................................................................................................................... Dimethyltryptamine ........................................................................................................................................................ Psilocybin ....................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................ 1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................. N-Benzylpiperazine ........................................................................................................................................................ MDPV (3,4-Methylenedioxypyrovalerone) ..................................................................................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................... Heroin ............................................................................................................................................................................ Normorphine .................................................................................................................................................................. Norlevorphanol ............................................................................................................................................................... Amphetamine ................................................................................................................................................................. Methamphetamine ......................................................................................................................................................... Nabilone ......................................................................................................................................................................... 1-Phenylcyclohexylamine .............................................................................................................................................. Phencyclidine ................................................................................................................................................................. Cocaine .......................................................................................................................................................................... Codeine .......................................................................................................................................................................... Ecgonine ........................................................................................................................................................................ 17:42 Apr 24, 2017 Jkt 241001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 II II II II II II II II II II II II respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on December 19, 2016, Sigma Aldrich Research Biochemicals, Inc., 1–3 Strathmore Road, Natick, Massachusetts 01760–2447 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance VerDate Sep<11>2014 9050 9143 9150 9193 9250 9254 9273 9300 9330 9333 9630 9652 Schedule E:\FR\FM\25APN1.SGM 25APN1 1235 1237 1248 1585 7249 7315 7370 7391 7392 7395 7396 7400 7402 7404 7405 7435 7437 7439 7470 7493 7535 7540 9200 9313 9634 1100 1105 7379 7460 7471 9041 9050 9180 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II

Agencies

[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)]
[Notices]
[Pages 19084-19085]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08347]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Siegfried 
USA, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before June 26, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on 
November 22, 2016, Siegfried USA, LLC, 33 Industrial Park Road, 
Pennsville, New Jersey 08070 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance             Drug code         Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...........            2010  I
Dihydromorphine.....................            9145  I
Hydromorphinol......................            9301  I
Methylphenidate.....................            1724  II
Amobarbital.........................            2125  II
Pentobarbital.......................            2270  II
Secobarbital........................            2315  II

[[Page 19085]]

 
Codeine.............................            9050  II
Oxycodone...........................            9143  II
Hydromorphone.......................            9150  II
Hydrocodone.........................            9193  II
Methadone...........................            9250  II
Methadone intermediate..............            9254  II
Dextropropoxyphene, bulk (non-dosage            9273  II
 forms).
Morphine............................            9300  II
Oripavine...........................            9330  II
Thebaine............................            9333  II
Opium tincture......................            9630  II
Oxymorphone.........................            9652  II
------------------------------------------------------------------------

    The company plans to manufacturer the listed controlled substances 
in bulk for distribution to its customers.

    Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-08347 Filed 4-24-17; 8:45 am]
 BILLING CODE 4410-09-P